Investor Presentaiton

1 Disclaimer This material may contain "forward-looking statements" within the meaning of the safe harbor provisions of the U. S. Private Securities Litigation Reform Act of 1995. Statements contained herein and in our 2015 Second Quarter Results press release that are not historical facts, including, without limitation, the following statements about Mindray's anticipated net revenues, non-GAAP net income and capital expenditure for 2015, our expected lower interest income for 2015, our assumption of a corporate income tax rate of 15% applicable to the Shenzhen subsidiary, our anticipated uncertainty of interest payment from certain short-term investments (where the principal amount is guaranteed but not the interest portion) in relation to $7.6 million interest receivable provision recorded by us in this second quarter of 2015, our continued assumption of the 2015 payments related to the recently announced employee incentive and talent retention program to be distributed half in equity based compensation and half in cash, statements that the exact impact of the assumption of the 2015 payments related to the recently announced employee incentive and talent retention program will depend on the actual split between equity based compensation and cash payments, that although the near-term outlook of our overall business remains challenging amid a difficult environment, we are working diligently to strengthen our competitive position and seize business opportunities, that we will continue to invest prudently into our global sales, marketing, and distribution networks, as well as product development capabilities, that we will continue to pursue attractive M&As and other partnerships opportunities to ensure the future success of Mindray and other statements under "Business Outlook for Full Year 2015" in our 2015 Second Quarter Results press release, statements that with a growing installation base for high-speed reagent-consuming products and the cellular analysis line in the domestic market, we remain optimistic about the prospects of this business, that we continue to anticipate modest market growth for the China sales in the foreseeable future, that we also see growing competition in the domestic market from both our local and international competitors, that we expect government initiatives and policies (eg. Improving county-level hospitals, priority purchase from local manufacturers, private hospital development, etc.) to be favorable for us over the long run, that overall, we continue to expect the emerging markets to remain weak in the foreseeable future, that we are fully committed to strengthening our presence in the emerging markets to seize long-term opportunities, that we will continue to optimize our local operational infrastructures and enhance our capabilities in public and private sector participation in the emerging markets, that we anticipate our performances in the European markets to be further affected by negative FX trends as well as increasing competition from Japanese and European companies, our 2015 guidance and our plans for 2015 are forward-looking statements. Forward- looking statements represent only the company's beliefs and predictions regarding future events, many of which, by their nature, are inherently uncertain and outside of the company's control. Our actual results and financial condition and other circumstances may differ materially from the anticipated results and financial condition indicated in these forward-looking statements due to a variety of risk, uncertainties and factors, including, without limitation, competitive, pricing and other conditions in China and our international markets and our ability to effectively address or respond those conditions; our ability effectively attract and retain our key employees; the growth and expected growth of the medical device market in China and internationally; applicable government policies and regulations; our ability to satisfy the requirements imposed by relevant regulatory bodies; market acceptance of our products; our expectations regarding demand for our products; our ability to expand our production, our sales and distribution network and other aspects of our operations; our ability to stay abreast of market trends and technological advances; our ability to effectively protect our intellectual property rights and not infringe on the intellectual property rights of others; our ability to settle disputes with our customers and suppliers; and general economic and business conditions in the countries in which we operate. For a discussion of other important factors that could adversely affect our business, financial condition, results of operations and prospects, see "Risk Factors" beginning on page 6 of our annual report on Form 20-F which was filed on April 16, 2015. Our results of operations for 2015 Second Quarter are not necessarily indicative of our operating results for any future periods. The financial information contained in this presentation and its related materials should be read in conjunction with the consolidated financial statements and notes thereto included in our public filings with the Securities and Exchange Commission. Any projections in this presentation and its related materials are based on limited information currently available to us, which is subject to change. Although such projections and the factors influencing them will likely change, we will not necessarily update the information. Such information speaks only as of the date of this presentation. mindray

View entire presentation